Has Jose Fernandez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,382 in general payments to Jose Fernandez, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jose Fernandez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jose Fernandez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jose Fernandez, MD

Pain Medicine · Miami, FLNPI 1679077499

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 33 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 28.9% of the total. That places this record below the midpoint for pain medicine clinicians in FL, where the typical reported total is $2,085.

$2,382in general payments, 2019–2025

Across 33 payments — averaging $72.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Saluda Medical Americas, Inc.$688
SPR Therapeutics, Inc$340
Abbott$209
Foundation Fusion Solutions, LLC$182
Medtronic$168
AbbVie$125
plus $670 from 9 others

$632in research payments, 2019–2025

Across 2 payments — averaging $316.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Genentech, Inc.$632

What the payments were for

Travel & lodging$382%
Food & beverage$2,34498%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Saluda Medical Americas, Inc.	7	$688
SPR Therapeutics, Inc	4	$340
Abbott	2	$209
Foundation Fusion Solutions, LLC	1	$182
Medtronic	1	$168
AbbVie	1	$125
Gilead	1	$121
Bristol Myers Squibb	3	$116
Curonix LLC	1	$109
Scilex Pharmaceuticals Inc.	4	$94
Nevro Corp.	1	$81
GSK	2	$47
Pfizer	2	$40
Seagen Inc.	2	$39
AstraZeneca	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Evoke$538
SPRINT PNS System$205
ETERNA$178
INTELLIS ADAPTIVESTIM$168
BOTOX$125
PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$109

How this compares

$2,382 in reported general payments places this provider in the 50th percentile of 596 pain medicine providers in Florida.

See all pain medicine providers in Florida →

Medicare billing

Part B allowed, 2024

$3,148

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	729	$14,188
Gabapentin	2,148	$12,591
Buprenorphine	55	$10,953
Celecoxib	418	$10,571
Pregabalin	500	$10,086
Lidocaine	158	$9,366
Acetaminophen-CodeineAcetaminophen With Codeine	403	$5,572
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	241	$3,906
Diclofenac Sodium	311	$3,555
Tramadol Hcl	725	$3,202
Baclofen	368	$2,483
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen	320	$1,943
Oxycodone Hcl	111	$1,814
Naloxone Hcl	27	$1,640
Fentanyl	15	$1,153

Paid to pharmacies, not to this prescriber.

Other pain medicine in Miami

Jeffrey GudinMiami$356K
Ruben SchwartzMiami$19K
Joseph PergolizziNaples$333K
Ramon Cuevas-TrisanRiviera Beach$220K
Navdeep JassalLakeland$163K
Mark-Friedrich HurdleJacksonville$140K
Rodolfo GariTampa$120K
Stephen PylesOcala$115K
Orlando FloreteJacksonville$86K
Michael GreeneMiddleburg$73K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →